{"public_id":"cl_bb14378ec76fe74f723ead100142bc7b","status":"active","superseded_by_public_id":null,"corpus_id":22826405,"text":"Long-acting insulin analogues showed only marginal hemoglobin A1c differences compared with neutral protamine Hagedorn insulin in adults with type 1 diabetes and type 2 diabetes.","confidence":0.97,"paper":{"corpus_id":22826405,"title":"Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis","url":"https://sah.borca.ai/papers/22826405"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_56152cb821e1353d3a006bbf75a9c5ef","name":"neutral protamine Hagedorn insulin","description":"An intermediate-acting human insulin preparation used as a comparator for long-acting insulin analogues.","types":["treatment"],"url":"https://sah.borca.ai/concepts/co_56152cb821e1353d3a006bbf75a9c5ef"},{"public_id":"co_b2910c3e2393810fdc0f23a47c720b22","name":"hemoglobin A1c","description":"A blood biomarker reflecting average long-term glycemic control.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_b2910c3e2393810fdc0f23a47c720b22"},{"public_id":"co_cc23b33f233697d3bed333bf37fca23a","name":"long-acting insulin analogues","description":"Insulin analogues designed to provide prolonged basal insulin coverage.","types":["treatment"],"url":"https://sah.borca.ai/concepts/co_cc23b33f233697d3bed333bf37fca23a"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_bb14378ec76fe74f723ead100142bc7b"}